Zentalis Pharmaceuticals, Inc. Increase (Decrease) in Deferred Income Taxes
Zentalis Pharmaceuticals, Inc. (ZNTL) reported Increase (Decrease) in Deferred Income Taxes of $769.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2023-03-01
- Zentalis Pharmaceuticals, Inc. increase (decrease) in deferred income taxes for fiscal 2022 was $769.00K, a 1502.08% increase from fiscal 2021.
- Zentalis Pharmaceuticals, Inc. increase (decrease) in deferred income taxes for fiscal 2021 was $48.00K.
- Zentalis Pharmaceuticals, Inc. increase (decrease) in deferred income taxes for fiscal 2020 was -$17.00K.
- Zentalis Pharmaceuticals, Inc. increase (decrease) in deferred income taxes for fiscal 2019 was $0.00.
| Period end | Increase (Decrease) in Deferred Income Taxes 12 month | Increase (Decrease) in Deferred Income Taxes 12 month as first filed |
|---|---|---|
| 2022-12-31 | $769.00K 10-K · filed 2023-03-01 | |
| 2021-12-31 | $48.00K 10-K · filed 2023-03-01 | $0.00 10-K · filed 2022-02-24 |
| 2020-12-31 | -$17.00K 10-K · filed 2023-03-01 | |
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |